Ethacrynic acid


  • Type: Loop diuretic
  • Dosage Forms:
  • Routes of Administration: PO, IV (ethacrynate sodium)
  • Common Trade Names: Edecrin

Adult Dosing

40mg furosemide = 20mg torsemide = 1mg bumetanide = 50 mg ethacrynic acid

  • Ethacrynic acid: 50 to 200 PO daily, adjust dose in 25mg increments
  • Ethacrynate sodium: 0.5 to 1 mg/kg IV, max 100mg per dose; average dose 50 mg.

Pediatric Dosing

  • Contraindicated in infants, safety/efficacy not well established in children
  • Ethacrynic acid: 25 mg PO daily initially, titrate in 25mg increments. Max dose 3 mg/kg/day
  • Ethacrynate sodium: dose not well established, titrate carefully

Special Populations

  • Pregnancy Rating: B
  • Lactation risk: Infant risk cannot be ruled out
  • Renal dosing: avoid use if GFR <10
  • Hepatic dosing: use smallest dose necessary to achieve adequate diuresis


  • Allergy to class/drug
  • Anuria
  • Severe renal disease: if worsening electrolyte imbalance, azotemia, or oliguria develops discontinue and do not reinitiate
  • If severe, watery diarrhea occurs, discontinue and do not reinitiate
  • Infants

Adverse Reactions


  • Electrolyte imbalances, hypocalcemia, hypokalemia, hyponatremia
  • GI bleed, GI perforation, diarrhea, pancreatitis
  • Agranulocytosis/neutropenia, thrombocytopenia
  • Thromboembolic disorder
  • Hepatic coma, jaundice
  • Ototoxicity, hearing loss


  • Half-life: 1-4h
  • Metabolism: Liver
  • Excretion: Mostly renal

Mechanism of Action

  • Loop diuretic: inhibits Na+/K+/2Cl symporter in ascending limb of loop of Henle, preventing reabsorption and thereby increasing urinary excretion of sodium, chloride, and potassium


See Also


    This article is issued from Wikem. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.